Overview

Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Status:
Unknown status

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Endostar with Gemcitabine-Carboplatin are more effective than Gemcitabine-Carboplatin alone in the treatment of Non-Small Cell Lung Cancer (NSCLC),and about Endostar ,Compared with intravenous, Continued vein-pumping maby is a more effective way.

Phase:

Phase 2

Details

Lead Sponsor:

Hunan Province Tumor Hospital

Treatments:

Carboplatin
Endostar protein
Gemcitabine